7381 - 7390 of 8801 Results
Title
Year
-
OPENTitle: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page: 246End Page: 246Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06534-8Best OA location URL: https://www.nature.com/articles/s41419-024-06534-8.pdfCitation Count: 5
-
OPENTitle: Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 76End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.003Best OA location URL: https://doi.org/10.1016/j.nbd.2018.09.003Citation Count: 18
-
OPENTitle: Templating of monomeric alpha-synuclein results in inflammation and SNpc dopamine neuron death in a genetic mouse model of induced synucleinopathyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-10705-8Best OA location URL: https://www.nature.com/articles/s41598-025-10705-8.pdfCitation Count: 0
- Regional gray matter changes and age predict individual treatment response in Parkinson's disease2018OPENTitle: Regional gray matter changes and age predict individual treatment response in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 21Issue #:Start Page: 101636End Page: 101636Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.101636Best OA location URL: https://doi.org/10.1016/j.nicl.2018.101636Citation Count: 25
-
OPENTitle: Interactions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia NigraJournal Name: Journal of NeurochemistryPublisher: WileyVol: 169Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/jnc.16298Best OA location URL: https://doi.org/10.1111/jnc.16298Citation Count: 1
-
RESTRICTEDTitle: End of life planning in parkinsonian diseasesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.026Citation Count: 9
-
OPENTitle: Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 206Issue #:Start Page: 106820End Page: 106820Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2025.106820Best OA location URL: https://doi.org/10.1016/j.nbd.2025.106820Citation Count: 0
- ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling2022OPENTitle: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signalingJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1083/jcb.202106046Best OA location URL: https://rupress.org/jcb/article-pdf/221/7/e202106046/1434249/jcb_202106046.pdfCitation Count: 75
-
OPENTitle: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotypeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 10Start Page: 714End Page: 721Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.447Best OA location URL: https://escholarship.org/uc/item/49p824jtCitation Count: 15
-
OPENTitle: Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fneur.2021.656342Best OA location URL: https://doi.org/10.3389/fneur.2021.656342Citation Count: 6